The cost of a year of targeted therapy for lung cancer ranges from tens of thousands of dollars to hundreds of thousands of dollars, and the cost of treatment is affected by a variety of factors.
Due to different pathological types of lung cancer, the targeted drugs used for treatment are different, and the price is also different; and even for the same type of lung cancer, due to different physical conditions of the patients and previous treatment programs, the targeted drugs used are also different, so the treatment cost will also be very different.
For example, domestic gefitinib tablets may cost about 10,000 to 25,000 yuan for one year of treatment, and in some areas belong to the reimbursement scope of medical insurance, so that patients need to bear fewer expenses at their own expense.
In addition, the price difference between domestic and imported targeted lung cancer drugs is relatively large, and the specific cost can be consulted with local doctors. The different reimbursement policies of medical insurance in different regions will also lead to different final costs.
Generally lung cancer patients need to undergo genetic test in the hospital before targeted drug treatment to clarify the gene mutation sites and drug sensitivity, so that the competent physician can choose the appropriate treatment plan. Patients should not use drugs on their own to avoid delaying their condition.
In addition, targeted drug therapy may cause adverse reactions such as rash, itchy skin, diarrhea, liver and kidney function damage, bone marrow suppression and so on. Therefore, if lung cancer patients need to take targeted drugs, please be sure to use them under the guidance of doctors.